Exact Mass: 468.2488
Exact Mass Matches: 468.2488
Found 500 metabolites which its exact mass value is equals to given mass value 468.2488
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Gentamicin A
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D005839 - Gentamicins
Clinofibrate
C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent > C98150 - Fibrate Antilipidemic Agent Clinofibrate (S-8527) is a hypelipidemic agent and a HMG-CoA reductase inhibitor.
Derazantinib
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor
hydroxyrepaglinide
hydroxyrepaglinide is a metabolite of repaglinide. Repaglinide is for the treatment of type II diabetes. It is supplied by Novo Nordisk. It is sold in Japan by Dainippon Sumitomo Pharma. Repaglinide belongs to the meglitinide class of blood glucose-lowering drugs. (Wikipedia)
Clinofibrate
C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent > C98150 - Fibrate Antilipidemic Agent Clinofibrate (S-8527) is a hypelipidemic agent and a HMG-CoA reductase inhibitor.
Gentamicin A sulfate
Ivabradine
Cardivin B
A germacranolide isolated from the aerial parts of Carpesium divaricatum. It exhibits cytotoxicity against the human tumor cells, A-549 (nonsmall cell lung), SK-OV-3 (ovary), SK-MEL-2 (skin), XF-498 (central nervous system) and HCT-15 (colon).
11alpha,12beta-dihydroxy-(20R,22R)-21,24-epoxy-1-oxowitha-2,5,25(27)-trien-22,26-olide|witharifeen
(20S,22S,23R,24S)-14beta,22:22,25-diepoxy-9,23-dihydroxyergosta-4,7,11-triene-3,6-dione|blazeispirol Y
(22R,Z)-4beta,16beta,27-trihydroxy-1-oxo-witha-2,5,17(20),24-tetraenolide|(4S,22R,Z)-4,16beta,27-trihydroxy-1-oxo-witha-2,5,17(20),24-tetraenolide
eucalyptal C
An organic heterotetracyclic compound whose skeleton is composed of 3,5-diformyl-isopentyl substituted phloroglucinol fused with a cadinane ring system. Isolated from Eucalyptus globulus, it exhibits antineoplastic activity.
20alpha-hydroxy-1,4-dioxo-5beta,6beta-epoxy-20R,22R-witha-2,24-dienolide
4alpha-acetoxy-3alpha-(3-acetoxy-2-methylbutyryloxy)-11-hydroxy-6,7-dehydroeudesman-8-one
withahisolide A|[(5R,6S,7S,8S,9S,10R,14S,20S,22R,24S,25S,26R)-6alpha,7alpha:22,26:24,25-triepoxy-5alpha,26-dihydroxy-17(13?18)-abeo-5alpha-ergost-2,12,16-trien-1-one]
10beta-dihydroxy-6alpha-2-methylbutyloxy-9beta-isobutyloxy-germacran-8alpha,12-olide|ineupatolide C
withahisolide B|[(5R,6S,7S,8S,9S,10R,20S,22R,24S,25S,26R)-6alpha,7alpha:22,26:24,25-triepoxy-5alpha,26-dihydroxy-17(13?18)-abeo-5alpha-ergost-2,13,16-trien-1-one]
4beta,8alpha-dihydroxy-5beta-isobutyroyloxy-9beta-(3-methylbutyroyloxy)-3-oxo-germacr-11(13)-en-7beta,12alpha-olide
Maoyerabdosin
Maoyerabdosin is a natural product found in Isodon macrocalyx and Isodon japonicus with data available.
eucalyptal A
An organic heterotetracyclic compound whose skeleton is composed of 3,5-diformyl-isopentyl substituted phloroglucinol fused with a cadinane ring system. Isolated from Eucalyptus globulus, it exhibits antineoplastic activity.
Ile His Ala Glu
4-DWA
4-Dehydrowithaferin A is a natural product found in Withania aristata with data available.
Ala Glu His Ile
Ala Glu His Leu
Ala Glu Ile His
Ala Glu Leu His
Ala His Glu Ile
Ala His Glu Leu
Ala His Ile Glu
Ala His Lys Asn
Ala His Leu Glu
Ala His Asn Lys
Ala Ile Glu His
Ala Ile His Glu
Ala Lys His Asn
Ala Lys Asn His
Ala Leu Glu His
Ala Leu His Glu
Ala Asn His Lys
Ala Asn Lys His
Asp His Val Val
Asp Val His Val
Asp Val Val His
Glu Ala His Ile
Glu Ala His Leu
Glu Ala Ile His
Glu Ala Leu His
Glu His Ala Ile
Glu His Ala Leu
Glu His Ile Ala
Glu His Leu Ala
Glu Ile Ala His
Glu Ile His Ala
Glu Leu Ala His
Glu Leu His Ala
Phe Phe Gly Val
Phe Phe Val Gly
Phe Gly Phe Val
Phe Gly Val Phe
Phe Val Phe Gly
Phe Val Gly Phe
Gly Phe Phe Val
Gly Phe Val Phe
Gly His Lys Gln
Gly His Gln Lys
Gly Lys His Gln
Gly Lys Gln His
Gly Gln His Lys
Gly Gln Lys His
Gly Val Phe Phe
His Ala Glu Ile
His Ala Glu Leu
His Ala Ile Glu
His Ala Lys Asn
His Ala Leu Glu
His Ala Asn Lys
His Asp Val Val
His Glu Ala Ile
His Glu Ala Leu
His Glu Ile Ala
His Glu Leu Ala
His Gly Lys Gln
His Gly Gln Lys
His Ile Ala Glu
His Ile Glu Ala
His Ile Ile Ser
His Ile Leu Ser
His Ile Ser Ile
His Ile Ser Leu
His Ile Thr Val
His Ile Val Thr
His Lys Ala Asn
His Lys Gly Gln
His Lys Asn Ala
His Lys Gln Gly
His Leu Ala Glu
His Leu Glu Ala
His Leu Ile Ser
His Leu Leu Ser
His Leu Ser Ile
His Leu Ser Leu
His Leu Thr Val
His Leu Val Thr
His Asn Ala Lys
His Asn Lys Ala
His Gln Gly Lys
His Gln Lys Gly
His Ser Ile Ile
His Ser Ile Leu
His Ser Leu Ile
His Ser Leu Leu
His Thr Ile Val
His Thr Leu Val
His Thr Val Ile
His Thr Val Leu
His Val Asp Val
His Val Ile Thr
His Val Leu Thr
His Val Thr Ile
His Val Thr Leu
His Val Val Asp
Ile Ala Glu His
Ile Ala His Glu
Ile Glu Ala His
Ile Glu His Ala
Ile His Glu Ala
Ile His Ile Ser
Ile His Leu Ser
Ile His Ser Ile
Ile His Ser Leu
Ile His Thr Val
Ile His Val Thr
Ile Ile His Ser
Ile Ile Ser His
Ile Leu His Ser
Ile Leu Ser His
Ile Ser His Ile
Ile Ser His Leu
Ile Ser Ile His
Ile Ser Leu His
Ile Thr His Val
Ile Thr Val His
Ile Val His Thr
Ile Val Thr His
Lys Ala His Asn
Lys Ala Asn His
Lys Gly His Gln
Lys Gly Gln His
Lys His Ala Asn
Lys His Gly Gln
Lys His Asn Ala
Lys His Gln Gly
Lys Asn Ala His
Lys Asn His Ala
Lys Pro Pro Gln
Lys Pro Gln Pro
Lys Gln Gly His
Lys Gln His Gly
Lys Gln Pro Pro
Leu Ala Glu His
Leu Ala His Glu
Leu Glu Ala His
Leu Glu His Ala
Leu His Ala Glu
Leu His Glu Ala
Leu His Ile Ser
Leu His Leu Ser
Leu His Ser Ile
Leu His Ser Leu
Leu His Thr Val
Leu His Val Thr
Leu Ile His Ser
Leu Ile Ser His
Leu Leu His Ser
Leu Leu Ser His
Leu Ser His Ile
Leu Ser His Leu
Leu Ser Ile His
Leu Ser Leu His
Leu Thr His Val
Leu Thr Val His
Leu Val His Thr
Leu Val Thr His
Asn Ala His Lys
Asn Ala Lys His
Asn His Ala Lys
Asn His Lys Ala
Asn Lys Ala His
Asn Lys His Ala
Pro Lys Pro Gln
Pro Lys Gln Pro
Pro Pro Lys Gln
Pro Pro Gln Lys
Pro Pro Gln Gln
Pro Gln Lys Pro
Pro Gln Pro Lys
Pro Gln Pro Gln
Pro Gln Gln Pro
Gln Gly His Lys
Gln Gly Lys His
Gln His Gly Lys
Gln His Lys Gly
Gln Lys Gly His
Gln Lys His Gly
Gln Lys Pro Pro
Gln Pro Lys Pro
Gln Pro Pro Lys
Gln Pro Pro Gln
Gln Pro Gln Pro
Gln Gln Pro Pro
Ser His Ile Ile
Ser His Ile Leu
Ser His Leu Ile
Ser His Leu Leu
Ser Ile His Ile
Ser Ile His Leu
Ser Ile Ile His
Thr Val Leu His
Val Asp His Val
Val Asp Val His
Val Phe Phe Gly
Val Phe Gly Phe
Val Gly Phe Phe
Val His Asp Val
Val His Ile Thr
Val His Leu Thr
Val His Thr Ile
Val His Thr Leu
Val His Val Asp
Val Ile His Thr
Val Ile Thr His
Val Leu His Thr
Val Leu Thr His
Val Thr His Ile
Val Thr His Leu
Val Thr Ile His
Val Thr Leu His
Val Val Asp His
Val Val His Asp
Ivabradine
C78274 - Agent Affecting Cardiovascular System > C47793 - Antiarrhythmic Agent COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C - Cardiovascular system > C01 - Cardiac therapy D002317 - Cardiovascular Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
4-[(3-ethenyl-6,10,10b-trihydroxy-3,4a,7,7,10a-pentamethyl-1-oxo-5,6,6a,8,9,10-hexahydro-2H-benzo[f]chromen-5-yl)oxy]-4-oxobutanoic acid
METHYL 3-(((2-CYCLOPENTYL-6,7-DIMETHYL-1-OXO-2,3-DIHYDRO-1H-INDEN-5-YL)OXY)METHYL)-[1,1-BIPHENYL]-4-CARBOXYLATE
2,2-METHYLENEBIS[6-(2-HYDROXY-5-METHYLBENZYL)-P-CRESOL]
HTH 01-015
HTH-01-015 is a selective NUAK1/ARK5 inhibitor (IC50 is 100 nM). HTH-01-015 inhibits NUAK1 with >100-fold higher potency than NUAK2 (IC50 of >10 μM).
(S)-benzyl 2-((S)-2-(tert-butoxycarbonylamino)-4-methylpentanamido)-3-phenylpropanoate
2,6-DIMETHYL-4-HEPTYL-B-D-MALTOPYRANOSIDE, ANAGRADE?
Klugine
An isoquinoline alkaloid that is emetan substituted by methoxy groups at positions 7 and 11 and hydroxy groups at positions 1, 6 and 10. Isolated from Psychotria klugii, it exhibits antileishmanial and antiplasmodial activities.
Tubocapsanolide A
A withanolide that is 5beta,6beta:16alpha,17alpha-diepoxywitha-2,24-dienolide substituted by a hydroxy group at position 4 and an oxo group at position 1. Isolated from Tubocapsicum anomalum, it exhibits cytotoxic activity.
calotropone
A 20-oxo steroid that is 17alpha-pregn-5-en-20-one substituted by a benzoyloxy group at position 12 and hydroxy groups at positions 3, 14 and 17 (the 3beta,12beta,14beta stereoisomer). It is isolated from the roots of Calotropis gigantea and displays inhibitory effects towards chronic myelogenous leukemia K562 and human gastric cancer SGC-7901 cell lines.
ethyl 4-[[(2S)-4-methyl-1-oxo-1-[[(2S)-1-oxo-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl]amino]pentan-2-yl]carbamoyloxy]piperidine-1-carboxylate
1-[3-Methyl-1-[1-[(4-methylphenyl)sulfonylmethyl]-5-tetrazolyl]butyl]-4-phenylpiperazine
acetic acid [(1R,4bR,5R,10aR,12aR)-1-(3-furanyl)-4b,7,7,10a,12a-pentamethyl-3,8-dioxo-5,6,6a,9,10,10b,11,12-octahydro-1H-naphtho[2,1-f][2]benzopyran-5-yl] ester
1-[(1-ethyl-3,4-dihydro-2H-quinolin-6-yl)methyl]-3-(3-methoxyphenyl)-1-[2-(4-morpholinyl)ethyl]thiourea
(1S,9R,10R,11R)-11-N-ethyl-10-(hydroxymethyl)-5-(2-methoxyphenyl)-6-oxo-12-N-propyl-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11,12-dicarboxamide
propan-2-yl N-[[(10S,11S)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylcarbamate
propan-2-yl N-[[(10S,11R)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylcarbamate
propan-2-yl N-[[(10S,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylcarbamate
(2R,3R,3aS,9bS)-7-(2-fluorophenyl)-3-(hydroxymethyl)-2-(4-methylpiperazine-1-carbonyl)-1-propyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizin-6-one
propan-2-yl N-[[(10R,11R)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylcarbamate
N-[(4S,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-[oxo(pyridin-4-yl)methyl]-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
N-[(4S,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-[oxo(pyridin-4-yl)methyl]-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
N-[(4R,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-[oxo(2-pyridinyl)methyl]-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
N-[(4R,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-[oxo(2-pyridinyl)methyl]-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
N-[(4R,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-[oxo(2-pyridinyl)methyl]-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
N-[(4S,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-[oxo(2-pyridinyl)methyl]-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
N-[(5S,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-[oxo(3-pyridinyl)methyl]-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
N-[(5R,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-[oxo(3-pyridinyl)methyl]-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
2-[(3R,6aS,8S,10aS)-1-[(4-fluorophenyl)methyl]-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-1-(3,4-dihydro-1H-isoquinolin-2-yl)ethanone
N-[(4R,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-[oxo(pyridin-4-yl)methyl]-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
N-[(4R,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-[oxo(pyridin-4-yl)methyl]-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
N-[(4S,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-[oxo(pyridin-4-yl)methyl]-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
N-[(4S,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-[oxo(2-pyridinyl)methyl]-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
N-[(4S,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-[oxo(2-pyridinyl)methyl]-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
N-[(4S,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-[oxo(2-pyridinyl)methyl]-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
N-[(4R,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-[oxo(2-pyridinyl)methyl]-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
N-[(5R,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-[oxo(3-pyridinyl)methyl]-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
N-[(5S,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-[oxo(3-pyridinyl)methyl]-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
N-[(5S,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-[oxo(3-pyridinyl)methyl]-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
propan-2-yl N-[[(10R,11S)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylcarbamate
(3R,6aR,8S,10aR)-3-hydroxy-8-[2-oxo-2-(2-pyridin-4-ylethylamino)ethyl]-N-phenyl-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocine-1-carboxamide
(1R,9S,10S,11S)-11-N-ethyl-10-(hydroxymethyl)-5-(2-methoxyphenyl)-6-oxo-12-N-propyl-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11,12-dicarboxamide
(2S,3S,3aR,9bR)-7-(2-fluorophenyl)-3-(hydroxymethyl)-2-[(4-methyl-1-piperazinyl)-oxomethyl]-1-propyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizin-6-one
propan-2-yl N-[[(10R,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylcarbamate
propan-2-yl N-[[(10R,11R)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylcarbamate
2-[(3R,6aS,8S,10aS)-1-[(2-fluorophenyl)methyl]-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-1-(3,4-dihydro-1H-isoquinolin-2-yl)ethanone
[3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] (Z)-pentadec-9-enoate
1-(9Z-pentadecenoyl)-glycero-3-phospho-(1-sn-glycerol)
1-(5-hydroxy-2-oxo-5h-furan-3-yl)-3b,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,4h,5h,5ah,9bh,10h,11h-cyclopenta[a]phenanthren-4-yl acetate
(3ar,4r,5r,6r,10r,11r,11as)-4,10-dihydroxy-6,10-dimethyl-3-methylidene-11-[(2-methylpropanoyl)oxy]-2,9-dioxo-octahydrocyclodeca[b]furan-5-yl 3-methylbutanoate
(4ar,5as,6ar,12as,12br)-12b-methyl-9-[(1s)-1-[(2r,4s,5r)-4,5,6-trihydroxy-4,5-dimethyloxan-2-yl]ethyl]-4h,5ah,6h,6ah,11h,12h,12ah-chryseno[6,6a-b]oxiren-1-one
(2r,3s,5r,6s)-6-[(4ar,5as,6ar,12as,12br)-12b-methyl-1-oxo-4h,5ah,6h,6ah,11h,12h,12ah-chryseno[6,6a-b]oxiren-9-yl]-2,3,5-trihydroxy-2,3-dimethylheptanal
15-[1-(4,5-dimethyl-6-oxo-2,3-dihydropyran-2-yl)ethyl]-5-hydroxy-10,14-dimethyl-3-oxapentacyclo[9.7.0.0²,⁴.0⁵,¹⁰.0¹⁴,¹⁸]octadec-7-ene-9,13-dione
(1'r,2s,3r,4s,10's,11's,14'r,15'r,16's)-3,11'-dihydroxy-4,5,5,10',14',16'-hexamethyl-18'-oxaspiro[oxolane-2,17'-pentacyclo[13.3.2.0¹,¹⁴.0²,¹¹.0⁵,¹⁰]icosane]-2',5',12'-triene-4',7'-dione
15-hydroxy-16-[5-(hydroxymethyl)-4-methyl-6-oxo-2,3-dihydropyran-2-yl]-10,14,16-trimethyl-17-oxapentacyclo[13.2.2.0¹,¹⁴.0²,¹¹.0⁵,¹⁰]nonadeca-4,6-dien-9-one
(1s,2s,3s,4r,7s,8z,12s,13r,14s,17s)-2-(acetyloxy)-3,14,17-trihydroxy-4,9,13,17-tetramethyl-5-oxo-6-oxatricyclo[11.4.0.0³,⁷]heptadec-8-en-12-yl acetate
4,5-bis(acetyloxy)-6-methyl-2-{[2-(4-methylcyclohex-3-en-1-yl)-5-oxopentan-2-yl]oxy}oxan-3-yl acetate
(1r,2r,10r,11s,14r,15r,16r)-15-hydroxy-16-[(2r)-5-(hydroxymethyl)-4-methyl-6-oxo-2,3-dihydropyran-2-yl]-10,14,16-trimethyl-17-oxapentacyclo[13.2.2.0¹,¹⁴.0²,¹¹.0⁵,¹⁰]nonadeca-4,7-dien-9-one
(1s,3ar,3br,4r,5as,9br,11s,11as)-1-(furan-3-yl)-4-hydroxy-3b,6,6,9a,11a-pentamethyl-3,7-dioxo-1h,2h,3ah,4h,5h,5ah,9bh,10h,11h-cyclopenta[a]phenanthren-11-yl acetate
16-[1-(4,5-dimethyl-6-oxo-2,3-dihydropyran-2-yl)ethyl]-6-hydroxy-2,17-dimethyl-8,15-dioxahexacyclo[9.8.0.0²,⁷.0⁷,⁹.0¹²,¹⁷.0¹⁴,¹⁶]nonadec-4-en-3-one
(2e)-n-{3-[(2s,5s)-5-{3-[(2e)-n,5-dihydroxy-3-methylpent-2-enamido]propyl}-3,6-dihydroxy-2,5-dihydropyrazin-2-yl]propyl}-5-hydroxy-3-methylpent-2-enimidic acid
1-(acetyloxy)-7-(2-hydroxypropan-2-yl)-1,4a-dimethyl-6-oxo-3,4,5,8a-tetrahydro-2h-naphthalen-2-yl 2-(acetyloxy)-3-hydroxy-2-methylbutanoate
(1s,2r,4r,6s,7s,10r,11r,16s,17r,18s)-6-(furan-3-yl)-17-hydroxy-1,7,11,15,15-pentamethyl-14-oxo-3-oxapentacyclo[8.8.0.0²,⁴.0²,⁷.0¹¹,¹⁶]octadec-12-en-18-yl acetate
6-{1-[6-hydroxy-2-(3-hydroxy-2-methylphenyl)-5a-methyl-5-oxo-octahydroindeno[5,4-b]furan-6-yl]ethyl}-3,4-dimethyl-5,6-dihydropyran-2-one
(1s,2r,7s,9r,11r,12r,16r)-15-[(1r)-1-[(2s)-4,5-dimethyl-6-oxo-2,3-dihydropyran-2-yl]-1-hydroxyethyl]-12-hydroxy-2,16-dimethyl-8-oxapentacyclo[9.7.0.0²,⁷.0⁷,⁹.0¹²,¹⁶]octadeca-4,14-dien-3-one
methyl 4-[(1r,3ar,5ar,9as,11ar)-3a,6,6,9a,11a-pentamethyl-3,4,7,10-tetraoxo-1h,2h,5h,5ah,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]pent-4-enoate
(1r,5r,8r)-8-[(1r,3as,3bs,5r,9ar,9bs,11r,11as)-5,11-dihydroxy-9a,11a-dimethyl-9-oxo-1h,2h,3h,3ah,3bh,4h,5h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-5-methyl-4-methylidene-2,6-dioxabicyclo[3.3.1]nonan-3-one
2-({9-methoxy-3,5-dimethylnaphtho[2,3-b]furan-4-yl}methyl)-3,4,5-trimethyl-5h,6h,7h,8h-naphtho[2,3-b]furan-9-ol
(1s,2r,7r,9s,11r,12s,16s)-15-[(1s)-1-[(1s,2r,6s)-2-hydroxy-1,6-dimethyl-3,7-dioxabicyclo[4.1.0]heptan-4-yl]ethyl]-2,16-dimethyl-8-oxapentacyclo[9.7.0.0²,⁷.0⁷,⁹.0¹²,¹⁶]octadeca-4,14-diene-3,13-dione
(10r,14r)-15-[(1s)-1-(4,5-dimethyl-6-oxo-2,3-dihydropyran-2-yl)ethyl]-5-hydroxy-10,14-dimethyl-3-oxapentacyclo[9.7.0.0²,⁴.0⁵,¹⁰.0¹⁴,¹⁸]octadec-7-ene-9,13-dione
16-hydroxy-4,8,12-trimethyl-2-(2-methylprop-1-en-1-yl)-17,18,19-trioxobicyclo[13.2.2]nonadeca-4,8,12,15-tetraen-1-yl acetate
(2r,3r)-2-{[(1s,4ar,5r,8as)-5-[(acetyloxy)methyl]-5,8a-dimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl]methoxy}-3-(methoxycarbonyl)pentanedioic acid
(1s,2r,6s,7r,9r,11r,14r,15s)-15-[(1s)-1-[(2r)-4,5-dimethyl-6-oxo-2,3-dihydropyran-2-yl]ethyl]-6,14-dihydroxy-2,15-dimethyl-8-oxapentacyclo[9.7.0.0²,⁷.0⁷,⁹.0¹²,¹⁶]octadeca-4,12(16)-dien-3-one
(1s,4s,12s,14s,17r,25r)-5,25-dimethyl-12-(3-methylbut-2-en-1-yl)-3,5,16,18-tetraazaheptacyclo[14.10.0.0³,¹⁴.0⁴,¹².0⁶,¹¹.0¹⁷,²⁵.0¹⁹,²⁴]hexacosa-6,8,10,19,21,23-hexaene-2,15-dione
(3r,6r,10r,13s,18as)-13-benzyl-11-hydroxy-3,6,8,10-tetramethyl-3h,4h,5h,6h,10h,13h,16h,17h,18h,18ah-pyrrolo[2,1-c]1-oxa-4,7-diazacyclohexadecane-1,9,14-trione
5-(9,12-dimethyl-3-oxo-10-{[(2-phenylacetyl)oxy]methyl}-2-oxatricyclo[6.3.1.0⁴,¹²]dodec-4-en-9-yl)-3-methylpentanoic acid
(1s,5r,7s,12r,13s,16s,17r,18r)-17-hydroxy-18-[(1s,2r,4r,6s)-2-hydroxy-1,6-dimethyl-3,7-dioxabicyclo[4.1.0]heptan-4-yl]-12,16-dimethyl-6-oxahexacyclo[15.2.1.0²,¹⁶.0³,¹³.0⁵,⁷.0⁷,¹²]icosa-2,9-dien-11-one
(4ar,4bs,10br,12r,12ar)-12,12a-dihydroxy-8-[(1s)-1-[(1s,2r,4r,6s)-2-hydroxy-1,6-dimethyl-3,7-dioxabicyclo[4.1.0]heptan-4-yl]ethyl]-4a-methyl-4b,5,6,10b,11,12-hexahydro-1h-chrysen-4-one
12-o-benzoylisolineolone
{"Ingredient_id": "HBIN000925","Ingredient_name": "12-o-benzoylisolineolone","Alias": "NA","Ingredient_formula": "C28H36O6","Ingredient_Smile": "CC(=O)C1CCC2(C1(C(CC3C2(CC=C4C3(CCC(C4)O)C)O)OC(=O)C5=CC=CC=C5)C)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "2246","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
azadironolide
{"Ingredient_id": "HBIN017434","Ingredient_name": "azadironolide","Alias": "NA","Ingredient_formula": "C28H36O6","Ingredient_Smile": "CC(=O)OC1CC2C(C(=O)C=CC2(C3C1(C4=CCC(C4(CC3)C)C5=CC(OC5=O)O)C)C)(C)C","Ingredient_weight": "468.6 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "2051","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "10814144","DrugBank_id": "NA"}